Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTSO | Common Stock | Gift | $0 | +2K | +2.52% | $0.00 | 81.3K | Feb 27, 2023 | Direct | F1, F2 |
transaction | CTSO | Common Stock | Gift | $0 | -2K | -100% | $0.00* | 0 | Feb 27, 2023 | Bernard Sobel Revocable Trust | F1 |
Id | Content |
---|---|
F1 | Reflects the transfer of shares to the reporting person from the Bernard Sobel Revocable Trust (the "Trust"), for which the reporting person is a trustee and a named beneficiary. |
F2 | Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change in Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 restricted stock units granted on March 15, 2018, (b) 6,000 restricted stock units granted on February 24, 2017, (c) 5,000 restricted stock units granted on June 7, 2016, and (d) 55,000 restricted stock units granted on April 8, 2015 and (ii) 12,000 shares of common stock owned directly by the reporting person. |